The treatment of myasthenia gravis;Die therapie der myasthenia gravis

Praxis

Volumn 90, Issue 33, 2001, Pages 1350-1354

  Rilling, G ^a   Tettenborn, B ^a,b  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b Klinik fur Neurologie   (Germany)

Author keywords

Myasthenia gravis; Treatment

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN;

IMMUNOSUPPRESSIVE TREATMENT; MYASTHENIA GRAVIS; PLASMAPHERESIS; REVIEW; THYMECTOMY; THYMOMA;

HUMANS; IMMUNIZATION, PASSIVE; IMMUNOSUPPRESSIVE AGENTS; MYASTHENIA GRAVIS; PLASMA EXCHANGE; THYMECTOMY; TREATMENT OUTCOME;

EID: 0035899273     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Ahlberg, R., Q. Yi, R. Pirskanen et al.: Treatment of myasthenia gravis with anti-CD4-antibody: Improvement correlates to decreased T-cell autoreactivity. Neurology 1994; 44: 1732-1737.
2. Badurska, B., B. Ryniewicz, H. Strugalska: Immunosuppressive treatment for juvenile myasthenia gravis. Eur J Pedatr 1992; 151 (3): 215-217.
3. Bamberg, C., R.W.C. Janzen, M. Szabados: Zur Langzeitbehandlung mit 7S-Immunglobulinen bei Myasthenia gravis. Vorläufige klinische Ergebnisse. Nervenarzt 1996; 67: 327-332.
4. Bonifati, D.M., C. Angelini: Long-term cyclosporine treatment in a group of severe myasthenia gravis patients. J Neurol 1997; 244 (9): 542-547.
5. Bromberg, M.B., J.J. Wald, D.A. Forshew et al.: Randomized trial of azathioprine or prednisone for initial immunosuppressive treatment of myasthenia gravis. J Neurol Sci 1997; 150 (1): 59-62.
6. Cosi, V., A. Citterio, M. Lombardi et al.: Effectiveness of steroid treatment in myasthenia gravis: a retrospective study. Acta Neurol Scand 1991; 84 (1): 33-39.
7. Crucitti, F., G.B. Doglietto, R. Bellantone et al.: Effects of surgical treatment in thymoma with myasthenia gravis: our experience in 103 patients. J Surg Oncol 1992; 50 (1): 43-46.
8. Engel, W.K., B.W. Festoff, B.M. Patten et al: Myasthenia gravis. Ann Intern Med 1974; 81: 225-246.
9. Evoli, A., A.P. Batocchi, C. Provenzano et al.: Thymectomy in the treatment of myasthenia gravis: report of 247 patients. J Neurol 1988; 235 (5): 272-276.
10. Fornadi, L., R. Horvath, A. Szobor: Myasthenia gravis: Treatment with plasma exchange experiences over 10 years. Acta Med Hung 1991; 48 (3-4): 137-144.
11. Furutama, D., H. Nakajima, K. Shinoda et al.: Lymphocytapheresis in combination with immunosuppressive drugs for refractory myasthenia gravis: Two colour flow cytometric analysis of changes in peripheral blood lymphocyte subsets. Eur Neurol 1995; 35: 270-275.
12. Gajdos, P., S. Chevret, B. Clair et al.: Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 1997; 41 (6): 789-796.
13. Hassantash, S.A., D.G. Ashbaugh, E.D. Verrier et al.: Surgical treatment of myasthenia gravis in two Middle East teaching hospitals: factors influencing outcome. Thorax 1996; 51: 193-196.
14. Havard, C.W.H., V. Fonseca: New treatment approaches to myasthenia gravis. Drugs 1990; 39 (1): 66-73.
15. Hosokawa, S., A. Oyamaguchi: Safety, stability, and effectiveness of immunoadsorption under membrane plasmapheresis treatment for myasthenia gravis. ASAIO Trans 1990; 36 (3): 207-208.
16. Howard, J.F.: Intravenous immunglobulin for the treatment of acquired myasthenia gravis. Neurology 1998; 51 (6 Supl. 5): 30-36.
17. Iani, C., M. Caramia, M. Morosetti et al.: The treatment of severe forms of myasthenia gravis. Funct Neurol 1998; 13 (3): 231-237.
18. Inderbitzi, R., L. Glutz, B. Nachbur: Die Bedeutung der Thymektomie in der Behandlung der Myasthenia gravis pseudoparalytica im Berner Krankengut. Schweiz Med Wschr 1986; 116: 1297-1302.
19. Jongen, J.L.M., P.A. van Doorn, F.G.A. van der Meche: High-dose intravenous immunoglobulin therapy for myasthenia gravis. J Neurol 1998; 245 (1): 26-31.
20. Mahalati, K., R.B. Dawson, J.O. Collins et al.: Predictable recovery from myasthenia gravis crisis with planta exchange: thirty-six cases and review of current management. J Clin Apharesis 1999; 14 (1): 1-8.
21. Mantegazza, R., C. Antonizzi, D. Pluchetti et al.: Azathioprine as a single drug or in combination with steroids in the treatment of myasthenia gravis. J Neurol 1988; 235 (8): 449-453.
22. Matell, G.: Immunosuppressive drugs: Azathioprine in the treatment of myasthenia gravis. Ann N Y Acad Sci 1987; 505: 589-594.
23. Mineo, T.C., F. Biancari, V. D'Andrea.: Late onset of myasthenia gravis after total resection of thymoma: report of two cases. J Cardiovasc Surg 1996; 37: 531-533.
24. Morosetti, M., C. Meloni, C. Iani et al.: Plasmapheresis in severe forms of myasthenia gravis. Artif Organs 1998; 22 (2): 129-134.
25. Nakamura, H., Y. Taniguchi, Y. Suzuki et al.: Delayed remission after thymectomy for myasthenia gravis of the purely ocular type. J Thorac Cardiovasc Surg 1996; 112 (2): 371-375.
26. Nieto, I.P., J.P. Robledo, M.C. Pajuelo et al.: Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases. Ann Thorac Surg 1999; 67 (6): 1568-1571.
27. Nix, W.A.: Indications and value of thymectomy in myasthenia gravis. Nervenarzt 1997; 68 (2): 85-93.
28. Novellino, L., M. Longoni, L. Spinelli et al.: "Extended" thymectomy, without sternotomy, performed by cervicotomy and thoracoscopic technique in the treatment of myasthenia gravis. Int Surg 1994; 79: 378-381.
29. Palace, J., J. Newsom-Davis, B. Lecky: Maysthenia Gravis Study Group: A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology 1998; 50 (6): 1778-1783.
30. Schumm, F., R. Hohlfeld: Myasthenia gravis und Myasthenie-Syndrom. In: Brandt, T., J. Dichgans, H.C. Diener (Hrsg): Therapie und Verlauf neurologischer Erkrankungen. Kohlhammer, Stuttgart, Berlin, Köln 1993: 1123-1149.
31. Seto, M., M. Motomura, G. Takeo et al.: Treatment of myasthenia gravis: A comparison of the natural course and current therapies. Tohoku J Exp Med 1993; 169: 77-86.
32. Seybold, M.E., D.B. Drachman: Gradually increasing doses of prednisone in myasthenia gravis. Reducing the hazards of treatment. N Engl J Med 1974; 290: 81-84.
33. Simpson, J.A., T. Thomaides: Treatment of myasthenia gravis: An audit. Q J Med 1987; 64 (244): 693-704.
34. Sommer, N., B. Sigg, A. Melms et al.: Ocular myasthenia gravis: response to long term immunosuppressive treatment. J Neurol Neurosurg Psychiatry 1997; 62: 156-162.
35. Stangel, M., H.P. Hartung, P. Marx et al.: Intravenous immunoglobulin treatment of neurological autoimmune diseases. J Neurol Sci 1998; 53 (2): 203-214.
36. Tindall, R.S.A., J.A. Rollins, J.T. Phillips et al.: Preliminary results of double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 1987; 316 (12): 719-724.
37. Tindall, R.S.A., J.T. Phillips, J.A. Rollins et al.: A clinical therapeutic trial of cyclosporine in myasthenia gravis. Ann N Y Acad Sci 1993; 681: 539-551.
38. Tsuchida, M., Y Yamato, T. Souma et al.: Efficacy and safety of extended thymectomy for elderly patients with myasthenia gravis. Ann Thorac Surg 1999; 67 (6): 1563-1567.
39. Tumani, H., A. Gorge, R. Nau: Myasthenic crisis caused by azathioprine-induced fever. Nervenarzt 1997; 68 (4): 336-338.
40. Verma, P., J. Oger: Treatment of acquired autoimmune myasthenia gravis: a topic review. Can J Neurol Sci 1992; 19 (3): 360-375.
41. Wakata, N., Y. Kawamura, M. Kobayashi et al.: Intermittend long-term acrenocorticosteroid treatment of myasthenia gravis. J Neurol 1991; 238 (1): 16-18.
42. Yeh, J.H., H.C. Chiu: Plasmapheresis in myasthenia gravis. A comparative study of daily alternately daily schedule. Acta Neurol Scand 1999; 99 (3): 147-151.